Avadel pharmaceuticals to present at the 11th annual svb leerink global healthcare conference

Dublin, ireland, feb. 10, 2022 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a company focused on transforming medicines to transform lives, announced today that greg divis, chief executive officer of avadel, will participate in a fireside chat at the 11th annual svb leerink global healthcare conference on thursday, february 17 at 1:40 p.m. et.
AVDL Ratings Summary
AVDL Quant Ranking